These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38021559)

  • 21. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
    Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
    J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Montelukast and budesonide combination for children with chronic cough-variant asthma.
    Wang XP; Yang LD; Zhou JF
    Medicine (Baltimore); 2018 Jul; 97(30):e11557. PubMed ID: 30045280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler.
    Möller M; Fritsche D; Rivera D; Libertus H
    Arzneimittelforschung; 2003; 53(8):562-7. PubMed ID: 13677246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
    Szefler SJ; Carlsson LG; Uryniak T; Baker JW
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Montelukast versus budesonide as a first line preventive therapy in mild persistent asthma in 2 to 18 y.
    Shah MB; Gohil J; Khapekar S; Dave J
    Indian J Pediatr; 2014 Jul; 81(7):655-9. PubMed ID: 24553973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of various second-line medications in addition to inhaled corticosteroid in asthma patients: a randomized controlled trial.
    Rajanandh MG; Nageswari AD; Ilango K
    Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):509-13. PubMed ID: 24738981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.
    Price DB; Hernandez D; Magyar P; Fiterman J; Beeh KM; James IG; Konstantopoulos S; Rojas R; van Noord JA; Pons M; Gilles L; Leff JA;
    Thorax; 2003 Mar; 58(3):211-6. PubMed ID: 12612295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009552. PubMed ID: 24043433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.
    Vaquerizo MJ; Casan P; Castillo J; Perpiña M; Sanchis J; Sobradillo V; Valencia A; Verea H; Viejo JL; Villasante C; Gonzalez-Esteban J; Picado C;
    Thorax; 2003 Mar; 58(3):204-10. PubMed ID: 12612294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
    Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma.
    Xu Z; Meng L; Xie Y; Guo W
    Braz J Med Biol Res; 2020; 53(7):e9271. PubMed ID: 32520202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial.
    Price DB; Swern A; Tozzi CA; Philip G; Polos P
    Allergy; 2006 Jun; 61(6):737-42. PubMed ID: 16677244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient response to the management during the acute presentation of cough variant Asthma: Retrospective cohort study.
    Ibrahim Arif S; Amer YS; Adnan Alkamal T; Abdulrahman Binsaeed M; Ibrahim Arif B; Dhaifallah Albaqami M; Bakri Alfahed O
    Saudi J Biol Sci; 2023 Dec; 30(12):103875. PubMed ID: 38058763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of montelukast sodium combined with budesonide or combined with loratadine in treating children with cough variant asthma and influence on inflammatory factors in the serum.
    Wei H; Li W; Jiang Z; Xi X; Qi G
    Exp Ther Med; 2019 Jul; 18(1):411-417. PubMed ID: 31258680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral corticosteroids for post-infectious cough in adults: study protocol for a double-blind randomized placebo-controlled trial in Swiss family practices (OSPIC trial).
    Merlo C; Essig S; Brancati-Badarau DO; Leuppi JD; Speich B; Erlanger TE; Hemkens LG; Zeller A
    Trials; 2020 Nov; 21(1):949. PubMed ID: 33225983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cough and asthma diagnosis: physicians' diagnosis and treatment of patients complaining of acute, subacute and chronic cough in rural areas of Japan.
    Yamasaki A; Hanaki K; Tomita K; Watanabe M; Hasagawa Y; Okazaki R; Yamamura M; Fukutani K; Sugimoto Y; Kato K; Kodani M; Ikeda T; Konishi T; Kawasaki Y; Tokuyasu H; Yajima H; Sejima H; Isobe T; Shimizu E
    Int J Gen Med; 2010 Apr; 3():101-7. PubMed ID: 20463827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma.
    Takemura M; Niimi A; Matsumoto H; Ueda T; Matsuoka H; Yamaguchi M; Jinnai M; Chin K; Mishima M
    Respiration; 2012; 83(4):308-15. PubMed ID: 22094623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    O'Shea O; Stovold E; Cates CJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the risk factors for acute, subacute and chronic cough: a cross-sectional study in a Finnish adult employee population.
    Lätti AM; Pekkanen J; Koskela HO
    BMJ Open; 2018 Jul; 8(7):e022950. PubMed ID: 30012794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.